Surrogate markers of effective anti-tumor immunity

Ann Surg Oncol. 2001 Apr;8(3):190-1. doi: 10.1007/s10434-001-0190-6.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, Neoplasm / metabolism
  • Biomarkers*
  • Cancer Vaccines*
  • Humans
  • Immunotherapy*
  • Neoplasms / diagnosis*
  • Neoplasms / therapy*
  • Prognosis

Substances

  • Antigens, Neoplasm
  • Biomarkers
  • Cancer Vaccines
  • TA90 immune complex